CNR Institutional Research Information System

PALMIERI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.554
NA - Nord America 4.233
EU - Europa 2.216
SA - Sud America 1.533
AF - Africa 166
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.994
SG - Singapore 3.827
CN - Cina 2.150
BR - Brasile 1.280
HK - Hong Kong 942
VN - Vietnam 849
IT - Italia 814
JP - Giappone 528
FR - Francia 505
KR - Corea 393
BD - Bangladesh 339
NL - Olanda 248
IN - India 151
DE - Germania 120
GB - Regno Unito 120
CA - Canada 116
AR - Argentina 90
FI - Finlandia 72
IL - Israele 67
MX - Messico 58
ID - Indonesia 51
ZA - Sudafrica 50
EC - Ecuador 44
AT - Austria 41
IE - Irlanda 38
IQ - Iraq 34
SA - Arabia Saudita 33
PL - Polonia 32
CO - Colombia 31
TR - Turchia 30
RU - Federazione Russa 27
UA - Ucraina 26
ES - Italia 24
MA - Marocco 24
VE - Venezuela 22
PK - Pakistan 21
TN - Tunisia 20
SE - Svezia 19
GR - Grecia 18
UY - Uruguay 18
EG - Egitto 17
KE - Kenya 17
MY - Malesia 17
PE - Perù 17
PY - Paraguay 17
JM - Giamaica 16
PH - Filippine 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
CR - Costa Rica 13
CZ - Repubblica Ceca 12
CH - Svizzera 9
DZ - Algeria 9
NO - Norvegia 9
NP - Nepal 9
PT - Portogallo 9
AL - Albania 8
AU - Australia 8
CL - Cile 8
KZ - Kazakistan 8
LT - Lituania 8
TH - Thailandia 8
BG - Bulgaria 7
HN - Honduras 7
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BE - Belgio 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
LV - Lettonia 5
OM - Oman 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
AO - Angola 4
CY - Cipro 4
DK - Danimarca 4
LK - Sri Lanka 4
MD - Moldavia 4
RS - Serbia 4
SI - Slovenia 4
BB - Barbados 3
BH - Bahrain 3
CU - Cuba 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
JO - Giordania 3
LB - Libano 3
LU - Lussemburgo 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GA - Gabon 2
KH - Cambogia 2
Totale 17.679
Salva come PNG Salva come JPEG
Città #
Singapore 2.237
Hefei 946
Hong Kong 936
Santa Clara 746
San Jose 556
Tokyo 464
Ashburn 416
Lauterbourg 409
Seoul 383
Ho Chi Minh City 301
Beijing 271
Hanoi 208
Dallas 177
New York 169
Los Angeles 167
Council Bluffs 144
São Paulo 131
Rome 78
Milan 67
Buffalo 65
Minamishinagawa 56
Boardman 51
Helsinki 50
Frankfurt am Main 46
Naples 46
Cavallino 44
Genoa 39
Rio de Janeiro 39
Cagliari 38
Orem 38
Guangzhou 37
Bengaluru 36
Dublin 36
Da Nang 35
Toronto 32
Amsterdam 31
Haiphong 31
Johannesburg 31
Montreal 31
Vienna 31
Belo Horizonte 30
Phoenix 28
Chicago 27
Porto Alegre 25
London 23
San Gregorio di Catania 23
Curitiba 22
Salvador 22
Bari 21
Manchester 21
Nuremberg 21
Chennai 19
Dhaka 19
Hải Dương 19
Mumbai 19
Warsaw 19
Brooklyn 18
Houston 18
Paris 18
Sassari 18
Stockholm 18
Campinas 17
Charlotte 17
Riyadh 17
Brasília 16
Denver 16
Florence 16
Düsseldorf 15
Montevideo 15
Turin 15
Boston 14
Jakarta 14
Nairobi 14
Sala Baganza 14
Shanghai 14
Tashkent 14
Biên Hòa 13
Fortaleza 13
Guayaquil 13
Atlanta 12
Goiânia 12
Hortolândia 12
Kingston 12
Madrid 12
Mexico City 12
Philadelphia 12
San Francisco 12
Buenos Aires 11
Quito 11
Quảng Ngãi 11
San José 11
Turku 11
Betim 10
Catania 10
Jeddah 10
Las Vegas 10
Marseille 10
Thái Nguyên 10
Asunción 9
Baghdad 9
Totale 10.593
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 121
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 117
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 94
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 87
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 87
Antitumoral effects of Vanadium compounds in malignant melanoma cell lines 87
ANTIPROLIFERATIVE ACTIVITY OF VANADIUM COMPOUNDS: EFFECTS ON THE MAJOR MALIGNANT MELANOMA MOLECULAR PATHWAYS 84
Anti- and Pro-Oxidant Activity of Polyphenols Extracts of Syrah and Chardonnay Grapevine Pomaces on Melanoma Cancer Cells 83
Analisi di mutazioni somatiche e germinali in geni candidati 80
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 80
The role of NEMO (NF-kB essential modulator) binding domain (NDB) peptide in inducing apoptosis in A375 melanoma cell line. 79
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 79
Stable integration and expression in mouse cells of yeast artificial chromosomes harboring human genes. 77
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 77
Il CSCC: aspetti distintivi della patologia 77
Iodinated 4,4’‐bipyridines with antiproliferative activity against melanoma cell lines 77
Germline and somatic NGS-based analysis on BRCA-related tumors 76
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 74
Construction of a pilot YAC library in a recombinant-defective yeast strain 74
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 74
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration 73
Attività anti-proliferativa e pro-apoptotica di bifenili derivati dall eugenolo e dall isoeugenolo su cellule tumorali di melanoma maligno. 72
Pancreatic cancer burden in North Sardinia, Italy 72
Idiopathic pulmonary fibrosis (IPF) and lung cancer 72
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe (R) Panel 72
What is changing in the adjuvant treatment of melanoma? 71
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 71
Second primary melanoma on a patient undergoing vemurafenib therapy. A case report. 69
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 69
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 69
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 69
Exploring interaction modes between polysaccharide-based selectors and biologically active 4,4'-bipyridines by experimental and computational analysis 68
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 68
Metronomic schedale of temozollomide with conventional dose of cisplatin in metastatic melanoma. 67
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 66
nalysis of Fanconi anemia genes in colorectal cancer. 66
Liquid biopsy in clinical oncology 66
Analisi mutazionali nei pazienti con tumori solidi 65
COLORECTAL CANCER EPIDEMIOLOGY IN AN AREA WITH A SPONTANEOUS SCREENING PROGRAM 65
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 65
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 64
Phenotype characterization of human melanoma cells resistant to Dabrafenib 64
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 64
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 64
Nanotecnologie Applicate alla classificazione MOlecolare delle MAlattie Complesse (NaMoMaC) 63
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 63
Current Trends in Mucosal Melanomas: An Overview 63
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 63
Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L 62
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 62
Molecular landscape profile of melanoma 62
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 61
PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis 61
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: a pilot study. 60
Genetic Instability Markers in Cancer 60
Analoghi strutturali della curcumina come potenziali agenti antitumorali contro il melanoma maligno. 59
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
The density and spatial tissue distribution of CD8(+) and CD163(+) immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors 58
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 57
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 57
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 56
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. 55
Screening genetico-molecolare del carcinoma della mammella e del cancro del colon-retto nel Nord Sardegna 55
In vitro and in vivo evaluation of the antitumour activity for a new curcumin-related compound in melanoma and neuroblastoma cells 55
Adjuvant therapy of cutaneous melanoma. 54
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the "Melanoma Research: A bridge from Naples to the World. Napoli, December 5 th-6 th2011" 54
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 54
Prevalence of BRCA1 and BRCA2 mutations in Sardinia. 54
AhR (Aryl Hydrocarbon Receptor) Polymorphisms: A Possible Role in TCDD (Dioxins)-AhR Binding and Carcinogenesis 54
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 54
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients. 54
Adjuvant treatment of malignant melanoma: Where are we? 52
Molecular classification of patients with malignant melanoma for new therapeutic strategies. 52
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 52
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 52
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 52
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis 51
Dioxin contamination in food chain: food and dioxins. 51
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 51
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy) 50
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 50
Ngs-based analysis of atypical deep penetrating nevi 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 50
Epithelioid cell-type melanoma as a prognostic factor of poor response to immunological treatment. 49
Le frontiere della diagnostica istopatologica e della genomica 49
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 49
Studio epidemiologico sull'incidenza dei tumori nei lavoratori e nella popolazione della zona industriale di Porto Torres 48
Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines 48
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 48
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 48
High-grade epithelial carcinoma arising in a low-grade epithelial myoepithelial carcinoma of the parotid gland: A rare case report with immunohistochemical and molecular analysis 47
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 47
Genetic alterations at chromosome 9p21 and melanoma progression. 47
A CXCR4 point mutation (G574A) detected in human cancer cell lines impaired tumor growth and affected ADM3100 sensitivity. 47
The enigmatic role of TP53 in germ cell tumours: Are we missing something? 47
Reproductive aging-associated common genetic variants and the risk of breast cancer. 47
Totale 6.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.981
article - articoli 47.697
book - libri 263
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.533
Totale 112.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202491 0 0 0 0 0 0 0 0 7 4 33 47
2024/20255.435 44 23 388 296 762 159 81 196 148 233 1.644 1.461
2025/202612.375 562 992 1.107 1.513 1.637 406 2.002 1.189 948 951 529 539
2026/2027362 362 0 0 0 0 0 0 0 0 0 0 0
Totale 18.263